ibusinesslines.com
ibusinesslines.com August 19, 2017


Immunotherapy is safe for people with Type 1 Diabetes

12 August 2017, 01:56 | Jodi Jackson

Currently type 1 diabetics must monitor their blood sugar and inject themselves with insulin Credit BSIP SA Alamy

Currently type 1 diabetics must monitor their blood sugar and inject themselves with insulin

Immunotherapies are regularly used in patients with autoimmune conditions, such as multiple sclerosis, rheumatoid arthritis, and lupus.

United Kingdom scientists may finally have uncovered an immune therapy that works against type 1 diabetes, based on the results of a small trial reported in Science Translational Medicine.

Researchers have been wary of pursuing the strategy in diabetes, anxious that it could accelerate or strengthen the immune system's attack on insulin-producing pancreatic cells, or cause risky allergic reactions.

Just as lab-produced chemical snippets of peanuts accustom an overactive immune system to the eventual introduction of real peanuts, the researchers hoped that the chemical flag they devised would teach the immune systems of newly diagnosed diabetics to recognize insulin and call off their attack on its source. As many as 1.25 million Americans are living with type 1 diabetes, and the autoimmune disorder's prevalence has been increasing in recent decades, with roughly 40,000 people diagnosed each year. The authors of the new study call their experimental treatment "an appealing strategy for prevention", both in the earliest stages of Type 1 diabetes and in children who are at high genetic risk of developing the disease.

Dr. Mark Peakman, a professor of clinical immunology at King's College London in England, said they found that the immunotherapy had the potential to stop the attacks on beta cells that make insulin.


Scientists are a step closer to finding a cure for diabetes, after they successfully created insulin-producing cells from skin using stem cell techniques.

Results showed there was no evidence of toxic side effects or accelerated B-cell destruction during the trial, nor during the six-month follow up period.

A larger study is needed to determine efficacy, but the small study has proven the safety profile of immunotherapy and its promising future as a therapy for treating type I diabetes. The non-treatment group, to the contrary, gradually needed more and more insulin doses in order to keep glycemic levels in check.

"We still have a long way to go, but these early results suggest we are heading in the right direction", he added. "The peptide technology used in our trial is not only appears to be safe for patients at this stage, but it also has a noticeable effect on the immune system", said Peakman.



Other News

Trending Now

Japan says can never tolerate North Korea provocations
In the event of war, North Korea's rocket forces-and possibly its nuclear weapons-will scatter to avoid detection. Guam elected its first governor in 1970 and, since 1972, has had one nonvoting delegate in the U.S.

The Walking Dead creator signs deal with Amazon
Analysts have estimated that Prime members spend more than double what nonmembers spend on Amazon.com. News of the Skybound/Amazon deal broke in The Hollywood Reporter this morning.

Two Barred From Iranian National Soccer Team For Playing Against Israeli Club
Shojaei was instrumental in helping Iran secure a spot in the 2018 World Cup, playing for 70 minutes against Uzbekistan. The comments set off vigorous discussion on social media in Iran, where soccer is the most popular sport.

Warriors Potentially Targeting Paul George In 2018
Durant has maintained from the beginning that his detractors merely want to see the Warriors fail. He was asked how his decision to take the pay cut came about.

Hearing in Penn State pledge's death begins 5th day
Attorney Leonard Ambrose announced his wish to call Bream to the stand, acknowledging that Bream was not in the courtroom Friday. The consent of Bream, 56, would undermine the element of recklessness involved in some of the allegations, Ambrose said.

Liverpool's Coutinho submits transfer request amid Barca interest
Coutinho is unavailable for the match, with Liverpool saying the playmaker has a back injury. On his relationship with FSG, Klopp added: "I'm not sure we need to prove [anything]".

Asteroid to come 'damn close' to crashing into Earth
The fireball measuring 18 meters across, screamed into Earth's atmosphere at 41,600 miles per hour . This asteroid is far enough away to be safe, but close enough to give scientists a lot to look at.